Angela McDonnell
Family · Saint Charles, MONPI 1952813958
Payments from drug & device makers
Across 198 payments — averaging $34.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- Sanofi$1K
- GSK$913
- AstraZeneca$742
- Harmony Biosciences LLC$523
- Regeneron Healthcare Solutions, Inc.$255
- plus $1K from 19 others
What the payments were for
- Consulting fees$6309%
- Travel & lodging$1,11616%
- Food & beverage$4,91372%
- Education$1192%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 9 | $1,562 |
| Sanofi | 22 | $1,431 |
| GSK | 56 | $913 |
| AstraZeneca | 29 | $742 |
| Harmony Biosciences LLC | 13 | $523 |
| Regeneron Healthcare Solutions, Inc. | 9 | $255 |
| Jazz Pharmaceuticals Inc. | 13 | $240 |
| Verona Pharma, Inc. | 6 | $230 |
| Avadel CNS Pharmaceuticals, LLC | 6 | $125 |
| Grifols USA, LLC | 5 | $109 |
| Sanofi-aventis U.S. LLC | 2 | $82 |
| Boehringer Ingelheim | 4 | $76 |
| Lilly USA, LLC | 3 | $72 |
| Axsome Therapeutics, Inc. | 4 | $67 |
| Itamar Medical Inc | 2 | $65 |
| Sanofi Pasteur Inc. | 3 | $63 |
| Amgen | 3 | $60 |
| Genentech USA, Inc. | 2 | $32 |
| Fisher & Paykel Healthcare Inc | 1 | $30 |
| Viatris Specialty LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Insmed, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,778 in reported general payments places this provider in the 95th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 532 | $470,253 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 209 | $139,851 |
| Breo ElliptaFluticasone/Vilanterol | 230 | $122,325 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 69 | $55,541 |
| Arnuity ElliptaFluticasone Furoate | 106 | $34,416 |
| EliquisApixaban | 33 | $32,383 |
| Spiriva RespimatTiotropium Bromide | 33 | $26,698 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 28 | $23,143 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 762 | $22,471 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $19,507 |
| Pulmicort FlexhalerBudesonide | 25 | $8,144 |
| Spiriva HandihalerTiotropium Bromide | 13 | $7,884 |
| SymbicortBudesonide/Formoterol Fumarate | 16 | $7,208 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 61 | $6,879 |
| Bevespi AerosphereGlycopyrrolate/Formoterol Fum | 15 | $6,846 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Arnuity Ellipta, Incruse Ellipta | $913 | $772,2541,094 claims |
| AstraZenecaBreztri Aerosphere, Pulmicort Flexhaler, Symbicort, Bevespi Aerosphere | $742 | $77,739125 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat, Combivent Respimat | $76 | $69,34872 claims |
| MerckDulera | $15 | $6,07914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,812 family providers in Missouri.
Other family in Saint Charles
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.